Medical treatments for male infertility
Copyright © 2023 Elsevier Masson SAS. All rights reserved..
BACKGROUND: Treatments to stimulate spermatogenesis and antioxidant food supplements are often offered to infertile patients either before sperm extraction surgery to improve results, or as part of medically assisted reproduction or spontaneous fertility to increase the likelihood of a live birth.
METHODS: A bibliographic search limited to English-language literature on men published before 5/2023 was carried out, including clinical trials, literature reviews and meta-analyses on spermatogenesis-stimulating molecules and antioxidant treatments.
RESULTS: Several medical treatments seem capable of improving male fertility: they act mainly by stimulating spermatogenesis through hormones, or by reducing the effects of oxidative stress. With regard to oligoasthenozoospermia, the literature shows that certain hormonal treatments stimulating spermatogenesis are useful. In the case of non-obstructive azoospermia, the value of treatment depends on the patient's FSH and testosterone levels. AOX supplementation appears to improve certain spermogram parameters and have an impact on pregnancy and live birth rates.
CONCLUSION: This review should help urologists gain a better understanding of the various medical treatments and enable them to define an appropriate therapeutic strategy, tailored to the patient and the couple, in order to obtain the best results.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:33 |
|---|---|
| Enthalten in: |
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie - 33(2023), 13 vom: 17. Nov., Seite 653-680 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
Traitements médicaux de l’homme infertile |
|---|
| Beteiligte Personen: |
Methorst, C [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 29.11.2023 Date Revised 29.11.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.purol.2023.09.019 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM365040916 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM365040916 | ||
| 003 | DE-627 | ||
| 005 | 20231226100830.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1016/j.purol.2023.09.019 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1216.xml |
| 035 | |a (DE-627)NLM365040916 | ||
| 035 | |a (NLM)38012910 | ||
| 035 | |a (PII)S1166-7087(23)00223-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Methorst, C |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Medical treatments for male infertility |
| 246 | 3 | 3 | |a Traitements médicaux de l’homme infertile |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.11.2023 | ||
| 500 | |a Date Revised 29.11.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 Elsevier Masson SAS. All rights reserved. | ||
| 520 | |a BACKGROUND: Treatments to stimulate spermatogenesis and antioxidant food supplements are often offered to infertile patients either before sperm extraction surgery to improve results, or as part of medically assisted reproduction or spontaneous fertility to increase the likelihood of a live birth | ||
| 520 | |a METHODS: A bibliographic search limited to English-language literature on men published before 5/2023 was carried out, including clinical trials, literature reviews and meta-analyses on spermatogenesis-stimulating molecules and antioxidant treatments | ||
| 520 | |a RESULTS: Several medical treatments seem capable of improving male fertility: they act mainly by stimulating spermatogenesis through hormones, or by reducing the effects of oxidative stress. With regard to oligoasthenozoospermia, the literature shows that certain hormonal treatments stimulating spermatogenesis are useful. In the case of non-obstructive azoospermia, the value of treatment depends on the patient's FSH and testosterone levels. AOX supplementation appears to improve certain spermogram parameters and have an impact on pregnancy and live birth rates | ||
| 520 | |a CONCLUSION: This review should help urologists gain a better understanding of the various medical treatments and enable them to define an appropriate therapeutic strategy, tailored to the patient and the couple, in order to obtain the best results | ||
| 650 | 4 | |a Review | |
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Anti-oxydants | |
| 650 | 4 | |a Antioxidants | |
| 650 | 4 | |a Aromatase inhibitors | |
| 650 | 4 | |a Citrate de clomifène | |
| 650 | 4 | |a Clomiphene citrate | |
| 650 | 4 | |a Gonadotrophines | |
| 650 | 4 | |a Gonadotropins | |
| 650 | 4 | |a Hormonal stimulation | |
| 650 | 4 | |a Infertilité masculine | |
| 650 | 4 | |a Inhibiteurs d’aromatase | |
| 650 | 4 | |a Male infertility | |
| 650 | 4 | |a Stimulation hormonale | |
| 650 | 4 | |a Tamoxifen | |
| 650 | 4 | |a Tamoxifène | |
| 650 | 7 | |a Antioxidants |2 NLM | |
| 700 | 1 | |a Faix, A |e verfasserin |4 aut | |
| 700 | 1 | |a Huyghe, E |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie |d 1997 |g 33(2023), 13 vom: 17. Nov., Seite 653-680 |w (DE-627)NLM012649481 |x 1166-7087 |7 nnns |
| 773 | 1 | 8 | |g volume:33 |g year:2023 |g number:13 |g day:17 |g month:11 |g pages:653-680 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.purol.2023.09.019 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 33 |j 2023 |e 13 |b 17 |c 11 |h 653-680 | ||